Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Forest Hills › NPI 1003427329
Agency

Future Care Registered Professional Nursing PLLC

Future Care Registered Professional Nursing PLLC was paid $169K by Medicaid between Sep 2021 and Nov 2024, across 18 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.

33Billing provider infoFUTURE CARE REGISTERED PROFESSIONAL NURSING PLLC
FOREST HILLS, NY 11375
33aNPI1003427329assigned 08/11/2020
33bProvider typeHome Infusion Agency
28Total paid$169K
24GClaims4,985
24DCodes billed18
24AFirst – last monthSep 2021 – Nov 2024
Compared with peers

Next to other Home Infusion Agency providers in New York

Rank by total paid#10 of 14
Median peer was paid$525K
This provider vs. median0.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20211,060$33K
20222,512$75K
2023793$30K
2024incomplete620$30K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 37% 870 747 $62K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 23% 1,063 909 $39K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 16% 509 508 $27K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 8.9% 181 179 $15K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 7.7% 310 227 $13K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2.4% 101 99 $4K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.7% 265 239 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 102 94 $2K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 909 760 $1K
87634 <1% 60 59 $991.85
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 68 68 $847.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 254 227 $269.07
6 more codes
93000 <1% 12 $145.93
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 28 $135.00
36415 Collection of venous blood by venipuncture <1% 94 $10.60
94760 <1% 30 $0.65
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 0% 63 $0.00
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 0% 66 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialYAAKOBOV, RAFAEL (NP)